Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.
about
Role of the tumor microenvironment in mature B-cell lymphoid malignanciesThe B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignanciesThe tumor microenvironment shapes hallmarks of mature B-cell malignancies.Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsSynergistic Cytotoxicity of Lenalidomide and Dexamethasone in Mantle Cell Lymphoma via Cereblon-dependent Targeting of the IL-6/STAT3/PI3K AxisA virtual screen identified C96 as a novel inhibitor of phosphatidylinositol 3-kinase that displays potent preclinical activity against multiple myeloma in vitro and in vivop38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.Impact of interleukin-6 in hematological malignancies.Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib.Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells.The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism.A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemiaToll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.Malignancies in systemic lupus erythematosus: a 2015 update.Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinomaLandscape of somatic mutations and clonal evolution in mantle cell lymphoma.Maternal IL-6 can cause T-cell-mediated juvenile alopecia by non-scarring follicular dystrophy in mice.Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastomaSignal transducer and activator of transcription 3 signaling upregulates fascin via nuclear factor-κB in gastric cancer: Implications in cell invasion and migration.Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?PI3K in cancer-stroma interactions: bad in seed and ugly in soil.gp130: a promising drug target for cancer therapy.Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin LymphomaIbrutinib for mantle cell lymphoma.TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated AutophagyROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy.Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma.ERK1/2 inhibition enhances apoptosis induced by JAK2 silencing in human gastric cancer SGC7901 cells.Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment.Ibrutinib: a strong candidate for the future of mantle cell lymphoma treatment.An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era.Study of Fibronectin Type III-Like Domains Role in Activation of gp130 Receptor.Multiple cytokine-producing testicular malignant lymphoma with clinical symptoms resembling infectious signs.Lactoferricin B reverses cisplatin resistance in head and neck squamous cell carcinoma cells through targeting PD-L1.Rationale for targeting tumor cells in their microenvironment for mantle cell lymphoma treatment.Characteristics of follicular and mantle cell lymphoma in Brazil: prognostic impact of clinical parameters and treatment conditions in two hospitalsThe Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological MalignanciesModelling the dynamics of HIV-related non-Hodgkin lymphomas in the presence of HIV treatment and chemotherapy
P2860
Q26748775-0308677C-3F9A-43CB-919D-04C6FEDAC736Q26822700-E23CFF59-184E-4A4F-8748-7CFBCEFCEAEDQ27687567-F542CA35-0D20-45E1-92AF-24DFC6629F0EQ28075606-38FC9FF1-3386-43F6-87BD-1B2C1241514CQ33817800-13E33F74-346E-407E-88AD-4870EB06B659Q33977088-AADC555C-D96E-4725-86D5-46235BED3DBCQ34356907-0DF8EA5E-F08A-48FE-BC1D-B5ED5A75B4BEQ34387624-79D42679-0BC4-4164-8C05-16E2E86C2637Q34648812-991CFEC5-B737-4AE4-961A-B9EA62C4D081Q35005510-9EFEC693-6A6A-4551-9B70-8D3B70D5B8C4Q35092818-7EE2B61D-9981-44EE-9017-13FA8E150D85Q35794593-9C85F3C0-690D-4DAE-AF8B-31EC4D2BFFDCQ36001708-35AAD456-F3A9-487B-A2E7-C4D0377E861FQ36035448-CBB82268-3748-4D91-8DEA-025FD3CA7D92Q36908883-38A734C3-68FE-430D-9487-C8D7E30DB87EQ37318226-39A803D9-5F6D-4FBD-AA5B-E0C82AC43E8BQ37375813-8D3AAA33-EE11-4082-893E-249393BEBF73Q37520595-1ED01590-5977-477C-92D7-AD14F01BB0DFQ37574906-B471014F-45B7-47F3-9B3E-65307F0AB05CQ38108302-5FD227D4-D083-4DAA-BE05-BDC4DAA7E058Q38124762-915DDA19-40BE-4018-9FA3-F0A9C8585382Q38149939-AA56BF3F-3703-4462-A391-D69590CF1962Q38551337-7A6E9658-AAF1-415C-8B61-4D05869867C9Q38694168-323D9F59-3A7D-43C0-BB8E-60AB18D690BAQ38734433-E179EDA1-B9F8-44AE-B94F-DD40D180824FQ38836849-940ED006-63DA-4961-95AE-F98EB22743F3Q38864150-B5934D51-AC15-40D9-9C29-2741EE92C1B0Q38887338-FFB3F924-52B7-4951-A8BD-64532578FB78Q38957093-4A0DB954-6611-4AF9-9008-63B3622CB977Q39068091-24EAC3FA-B8BC-4D6A-9408-7EB5B242C0B6Q39991268-DFA137CA-D945-41D1-BE68-17D6BFA027BBQ42710884-75D273A3-E3A5-4F48-9E8E-DC9D1DF3AAA7Q47151590-A5DEC82F-25EA-4202-8464-A9C018233A28Q51716199-B8E0F173-1E1C-439E-875E-964C84E75512Q53060407-BAFD4E39-E17C-44D8-92AC-F04A1AEA22C7Q53682256-D2DD0F79-2421-4E4D-A11F-CF4EF5D563BAQ53730905-FF4AD520-55B4-4A36-B20A-E756AD7F8119Q58124869-64F60665-CEA3-410B-A68B-16EE69F2FD5DQ58742654-B1C224FC-F560-4B8C-B95D-9E726563FC04Q59006109-8A67B3B7-AE23-4A68-BC4E-0300E37B4EB0
P2860
Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Role of the microenvironment i ...... al factor for the tumor cells.
@ast
Role of the microenvironment i ...... al factor for the tumor cells.
@en
type
label
Role of the microenvironment i ...... al factor for the tumor cells.
@ast
Role of the microenvironment i ...... al factor for the tumor cells.
@en
prefLabel
Role of the microenvironment i ...... al factor for the tumor cells.
@ast
Role of the microenvironment i ...... al factor for the tumor cells.
@en
P2093
P2860
P1433
P1476
Role of the microenvironment i ...... al factor for the tumor cells.
@en
P2093
Jianfei Qian
Jorge E Romaguera
Larry W Kwak
Liang Zhang
Michael Wang
P2860
P304
P356
10.1182/BLOOD-2012-04-424630
P407
P577
2012-09-11T00:00:00Z